This second largest country in the world progresses even more and as a first-world country, that's saying something. All this made possible due to the stereotypical fact-stereotypical, but mostly correct-that basically everything about it, from the people to places to policies, is nice.
Canada's health care system, on the other hand, has its ups and downs, considerably on the weak side when it comes to statistics and comparisons particularly to the United States. Yes, the US spends more on health care and all, but still it is an undeniable fact that Canada's system per se is still one of the most competitive in the continent and in the world.
The World Health Report 2000 released by the World Health Organization ranked countries' health care systems, wherein France came first. The United States surprisingly came in 37th, while Canada came in 30th. This report however, was received with criticisms and doubts as to the factors considered in coming up with the results. But one way or another, it is safe to conclude that Canadian health care is indeed a top-notch system.
Consequently, Canadian pharmacy follows the trend. The Canadian pharmaceutical market ranks eighth largest in the world, and the pharmaceutical industry, the fourth fastest growing one, its favor leaning in to the generic drugs rather than the branded. Canadian pharmacy proves to be a high-risk industry, what with all the market competition tightening more and more, among many other factors. However, as the principle of financial management goes, the higher the risk, the higher the return. As a result, this industry enjoys growing share of profits as time goes, as compared to other industries.
Certain associations have also been formed to further foster the needs of the industry and of the people, and how the Canadian pharmacy can aid to it; one of which is the worsening case of drug shortages. If you can't picture worsening, imagine penicillin: running out.
Canadian Medical Association has directed its attention to the said issue and it all comes down to questioning why the drugmakers cannot produce the said necessity.
Dr. Joel Lexchin, a York University professor specializing in health policy and the pharmaceutical industry, however, came up with possible solutions, starting with the mandatory reporting of the problem since it is not the industry's policy to disclose such information. A warning when a company decides to stop producing the drug six months prior to the discontinuance should also be made known to public. These suggestions were laid down in 2012, 2013, 2014 and 2015. Lexchin now thinks the predicament has worsened to the point that his 2015 suggestion won't work anymore.
|Harry Smith||012-1234 5678||Accounts Department|
|Susan Jenkins||012-2345 6789||Marketing Whizzkids|
|Todd Rhodes||012-3456 7891||Manufacturing|
|Wendy Kline||012-4567 8912||Customer Care|
Some drug companies voluntarily post whether or not a drug is available. Among these are eight companies, members of Canadian Generic Pharmaceutical Industry (CGPA). CGPA is among the pharmaceutical alliances in Canada, all, a group of pharmaceutical companies aimed at convening and helping settle certain matters and serving to their causes. Among others are Canadian International Pharmacy Association which extends beyond Canadian pharmacy, and the Canadian Agency for Drugs and Technologies in Health which gives studies, proofs, and recommendations to decision-makers to ensure security with their health decisions.
CGPA lays down that the reason why there are drug shortages depends on so many factors such as active ingredient quality and availability, manufacturing issues, regulatory issues and marketplace issues. This means that certain policies on drug production can, but not always, affect the continuous flow of drugs.
In order to boost drug research in the country, companies are allowed to patent a drug for twenty years. That means only they have the right to sell the drug, and after the span of twenty years, the branded drug becomes a generic, a drug status that allows any other company to sell it. The twenty-year monopoly period is given to allow the researcher to charge higher price in order to regain the research costs.
The endless progression of technology has satisfied not only the social necessities and entertainment facets of living. Even the health care aspect benefits from the endless capabilities of the online world. Online buying and selling is not entirely new, and it wouldn't be so surprising to know that trade of medicines via the internet is actually happening.